Longboard Pharmaceuticals, Inc.

NASDAQ (USD): Longboard Pharmaceuticals, Inc. (LBPH)

Last Price

15.67

Today's Change

-1.88 (10.71%)

Day's Change

15.64 - 17.32

Trading Volume

91,378

Overview

Market Cap

1 Billion

Shares Outstanding

38 Million

Avg Volume

432,354

Avg Price (50 Days)

20.76

Avg Price (200 Days)

15.19

PE Ratio

-15.50

EPS

-2.25

Earnings Announcement

01-Aug-2024

Previous Close

31.91

Open

32.07

Day's Range

31.59 - 35.59

Year Range

3.6 - 35.59

Trading Volume

751,083

Price Change Highlight

1 Day Change

9.28%

5 Day Change

28.81%

1 Month Change

98.69%

3 Month Change

93.29%

6 Month Change

38.37%

Ytd Change

38.92%

1 Year Change

389.06%

3 Year Change

279.02%

5 Year Change

109.43%

10 Year Change

109.43%

Max Change

109.43%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment